China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 26.55
(-0.19%)
CNY 26.55
(-0.19%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 237.46 Million CNY | -45.06% |
| 2022 | 432.19 Million CNY | 25.45% |
| 2021 | 344.52 Million CNY | 32.48% |
| 2020 | 260.06 Million CNY | -38.97% |
| 2019 | 426.14 Million CNY | -9.17% |
| 2018 | 469.17 Million CNY | 31.57% |
| 2017 | 356.58 Million CNY | 31.08% |
| 2016 | 272.04 Million CNY | 79.21% |
| 2015 | 151.79 Million CNY | 45.71% |
| 2014 | 104.17 Million CNY | 26.43% |
| 2013 | 82.4 Million CNY | 9.66% |
| 2012 | 75.14 Million CNY | 15.19% |
| 2011 | 65.23 Million CNY | 30.53% |
| 2010 | 49.97 Million CNY | 58.76% |
| 2009 | 31.47 Million CNY | 193.83% |
| 2008 | 10.71 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 152.02 Million CNY | 167.09% |
| 2024 Q3 | 96.73 Million CNY | -41.0% |
| 2024 Q2 | 163.94 Million CNY | 7.84% |
| 2023 Q3 | 138.14 Million CNY | -11.22% |
| 2023 Q2 | 155.6 Million CNY | -8.64% |
| 2023 Q1 | 170.31 Million CNY | 1123.68% |
| 2023 FY | 237.46 Million CNY | -45.06% |
| 2023 Q4 | -226.6 Million CNY | -264.03% |
| 2022 Q4 | 13.91 Million CNY | -90.02% |
| 2022 Q1 | 103.55 Million CNY | 391.47% |
| 2022 Q2 | 175.28 Million CNY | 69.27% |
| 2022 FY | 432.19 Million CNY | 25.45% |
| 2022 Q3 | 139.44 Million CNY | -20.45% |
| 2021 Q1 | 100.73 Million CNY | 178.36% |
| 2021 Q4 | 21.07 Million CNY | -83.24% |
| 2021 Q3 | 125.74 Million CNY | 29.66% |
| 2021 Q2 | 96.97 Million CNY | -3.73% |
| 2021 FY | 344.52 Million CNY | 32.48% |
| 2020 FY | 260.06 Million CNY | -38.97% |
| 2020 Q4 | 36.18 Million CNY | -42.34% |
| 2020 Q3 | 62.75 Million CNY | -3.76% |
| 2020 Q2 | 65.21 Million CNY | -32.0% |
| 2020 Q1 | 95.9 Million CNY | -10.97% |
| 2019 Q2 | 123.96 Million CNY | 38.97% |
| 2019 Q4 | 107.72 Million CNY | 2.34% |
| 2019 Q1 | 89.2 Million CNY | -51.21% |
| 2019 FY | 426.14 Million CNY | -9.17% |
| 2019 Q3 | 105.26 Million CNY | -15.09% |
| 2018 Q2 | 118.43 Million CNY | 63.3% |
| 2018 Q4 | 182.8 Million CNY | 91.62% |
| 2018 FY | 469.17 Million CNY | 31.57% |
| 2018 Q3 | 95.4 Million CNY | -19.45% |
| 2018 Q1 | 72.52 Million CNY | -45.48% |
| 2017 FY | 356.58 Million CNY | 31.08% |
| 2017 Q2 | 90.27 Million CNY | 33.83% |
| 2017 Q3 | 65.82 Million CNY | -27.09% |
| 2017 Q1 | 67.45 Million CNY | -26.96% |
| 2017 Q4 | 133.03 Million CNY | 102.11% |
| 2016 FY | 272.04 Million CNY | 79.21% |
| 2016 Q4 | 92.35 Million CNY | 24.84% |
| 2016 Q1 | 38.54 Million CNY | -18.81% |
| 2016 Q2 | 67.16 Million CNY | 74.26% |
| 2016 Q3 | 73.98 Million CNY | 10.15% |
| 2015 Q1 | 45.22 Million CNY | 36.2% |
| 2015 Q3 | 33.65 Million CNY | 32.25% |
| 2015 Q4 | 47.46 Million CNY | 41.03% |
| 2015 Q2 | 25.44 Million CNY | -43.73% |
| 2015 FY | 151.79 Million CNY | 45.71% |
| 2014 Q2 | 25.19 Million CNY | 30.75% |
| 2014 Q1 | 19.26 Million CNY | -24.17% |
| 2014 FY | 104.17 Million CNY | 26.43% |
| 2014 Q4 | 33.2 Million CNY | 25.21% |
| 2014 Q3 | 26.51 Million CNY | 5.26% |
| 2013 Q3 | 18.84 Million CNY | -11.15% |
| 2013 Q4 | 25.4 Million CNY | 34.84% |
| 2013 FY | 82.4 Million CNY | 9.66% |
| 2013 Q1 | 16.94 Million CNY | -17.61% |
| 2013 Q2 | 21.2 Million CNY | 25.19% |
| 2012 FY | 75.14 Million CNY | 15.19% |
| 2012 Q4 | 20.56 Million CNY | -0.88% |
| 2012 Q2 | 17.44 Million CNY | 6.46% |
| 2012 Q3 | 20.74 Million CNY | 18.91% |
| 2012 Q1 | 16.38 Million CNY | 15.83% |
| 2011 Q1 | 15.37 Million CNY | 0.0% |
| 2011 FY | 65.23 Million CNY | 30.53% |
| 2011 Q2 | 16.97 Million CNY | 10.41% |
| 2011 Q3 | 18.73 Million CNY | 10.41% |
| 2011 Q4 | 14.14 Million CNY | -24.5% |
| 2010 FY | 49.97 Million CNY | 58.76% |
| 2009 FY | 31.47 Million CNY | 193.83% |
| 2008 FY | 10.71 Million CNY | 0.0% |